AlphaFold predicted structure
LPIN2 · Q92539

Mean pLDDT
60.5/ 100
Low
896 residues
Confidence breakdown
- Very high(≥ 90)23%
- Confident(70–90)18%
- Low(50–70)11%
- Very low(< 50)49%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
lipin 2
Annotations refreshed 10 hours ago.
Diagnostic Grade (Green)
Autoinflammatory disorders
BIALLELIC, autosomal or pseudoautosomalCOVID-19 research
BIALLELIC, autosomal or pseudoautosomalCytopenias and congenital anaemias
BIALLELIC, autosomal or pseudoautosomalPeriodic fever syndromes
BIALLELIC, autosomal or pseudoautosomalPrimary immunodeficiency or monogenic inflammatory bowel disease
BIALLELIC, autosomal or pseudoautosomalRare anaemia
BIALLELIC, autosomal or pseudoautosomalSkeletal dysplasia
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalMajeed syndrome
congenital dyserythropoietic anemia
microcytic anemia
neurodegenerative disease
autoinflammatory syndrome
hypopituitarism
polymyalgia rheumatica
lung cancer
hereditary disease
chronic laryngitis
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Phosphatidate phosphatase LPIN2
Acts as a magnesium-dependent phosphatidate phosphatase enzyme which catalyzes the conversion of phosphatidic acid to diacylglycerol during triglyceride, phosphatidylcholine and phosphatidylethanolamine biosynthesis in the endoplasmic reticulum membrane. Plays important roles in controlling the metabolism of fatty acids at different levels. Also acts as a nuclear transcriptional coactivator for PPARGC1A to modulate lipid metabolism
LPIN2 · Q92539

Mean pLDDT
60.5/ 100
Low
896 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0